1. Alvarez, C. & Mohan, V. (2018) Systolic heart failure in a patient with primary aldosteronism. BMJ Case Rep., 2018, 225145.
2. Catena, C., Colussi, G., Nait, F., Martinis, F., Pezzutto, F. & Sechi, L.A. (2014) Aldosterone and the heart: still an unresolved issue? Front. Endocrinol. (Lausanne), 5, 168.
3. Forrester, J.S., Diamond, G., Chatterjee, K. & Swan, H.J. (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N. Engl. J. Med., 295, 1404-1413.
4. Francis, G.S. & Tang, W.H. (2003) Beta-blockers and reverse remodeling: what are the implications? Am. Heart J., 145, 200-202.
5. Hoshikawa, E., Matsumura, Y., Kubo, T., Okawa, M., Yamasaki, N., Kitaoka, H., Furuno, T., Takata, J. & Doi, Y.L. (2011) Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta blockers in patients with idiopathic dilated cardiomyopathy. Am. J. Cardiol., 107, 1065-1070.